CervoMed Inc (CRVO:NASDAQ)

$4.11 0.10 (2.49%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 87

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed CervoMed Inc (CRVO:NASDAQ) News Sources

CervoMed Inc.: CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies

FinanzNachrichten.de

CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies

Yahoo Finance

CervoMed to Participate in Upcoming Investor Conferences

Markets Insider

Study to explore neflamapimod in ALS

Healio

CRVO stock
CRVO stock price
CRVO stock price today
CRVO stock prediction
CRVO earnings date
CRVO news
CRVO price
CRVO share
CRVO share price
CRVO shares
CRVO ceo
CRVO premarket
$CRVO
CRVO ticker
CRVO after hours
CRVO stock
CRVO stock price
CRVO stock price today
CRVO stock prediction
CRVO earnings date
CRVO news
CRVO price
CRVO share
CRVO share price
CRVO shares
CRVO ceo
CRVO premarket
$CRVO
CRVO ticker
CRVO after hours

CervoMed Inc (CRVO:NASDAQ) FAQs

toggle

What is the current price of CervoMed Inc (CRVO:NASDAQ)?

The current price of CervoMed Inc (CRVO:NASDAQ) is $4.11.


toggle

CervoMed Inc (CRVO:NASDAQ) absolute price change since previous trading day?

The absolute price change of CervoMed Inc (CRVO:NASDAQ) since the previous trading day is $0.10.


toggle

CervoMed Inc (CRVO:NASDAQ) percentage price change since previous trading day?

The percentage price change of CervoMed Inc (CRVO:NASDAQ) since the previous trading day is 2.49%.


toggle

What is This Week's average sentiment score for CervoMed Inc (CRVO:NASDAQ)?

This Week's average sentiment score for CervoMed Inc (CRVO:NASDAQ) is 87 out of 100.


toggle

What is This Week's average sentiment for CervoMed Inc (CRVO:NASDAQ)?

This Week's sentiment for CervoMed Inc (CRVO:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.